Cite
HARVARD Citation
Karunakaran, D. et al. (2021). RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice. Circulation. 143 (2), p. . [Online].